تفاعل #1269872

ord-5d3525e1d1f34ae3939160f2002a5635

معادلة التفاعل

COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)O)c12
2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetic acid
c1ccc(-n2nnnc2N2CC3(CNC3)C2)cc1
2-(1-phenyl-1H-tetrazol-5-yl)-2,6-diazaspiro[3.3]heptane
CN(C)[P+](On1nnc2ccccc21)(N(C)C)N(C)C.F[P-](F)(F)(F)(F)F
BOP reagent
CCN(C(C)C)C(C)C
Hunig's base
COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4(C3)CN(c3nnnn3-c3ccccc3)C4)c12
1-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(6-(1-phenyl-1H-tetrazol-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl)ethane-1,2-dione
المردود 34.4%

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    أخرىThe mixture was quenched with methanol (10 mL) and volatiles
  2. 2
    أخرىwere removed under reduced pressure
  3. 3
    workup.ADDITIONThe resulting oil was diluted with ethyl acetate (50 mL)
  4. 4
    غسيلwashed with 10% NaHCO3 (10 mL) and brine (10 mL)
  5. 5
    تجفيفThe organic layer was dried over anhydrous Na2SO4
  6. 6
    تركيزconcentrated under reduced pressure
  7. 7
    أخرىThe resulting crude was purified by silica gel column chromatography

الإجراء التجريبي

2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetic acid (0.050 g), 2-(1-phenyl-1H-tetrazol-5-yl)-2,6-diazaspiro[3.3]heptane (0.044 g), BOP reagent (0.080 g) and Hunig's base (0.2 mL) were mixed in dry DMF (2 mL). The reaction mixture was stirred at room temperature for 16 hours. The mixture was quenched with methanol (10 mL) and volatiles were removed under reduced pressure. The resulting oil was diluted with ethyl acetate (50 mL), washed with 10% NaHCO3 (10 mL) and brine (10 mL). The organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. The resulting crude was purified by silica gel column chromatography using MeOH/CHCl3 (1:9) as an eluent to afford 1-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(6-(1-phenyl-1H-tetrazol-5-yl)-2,6-diazaspiro[3.3]heptan-2-yl)ethane-1,2-dione (30 mg). 1H NMR (400 MHz, DMSO-d6): δ ppm 2.47-2.49 (s, 3H), 3.93 (s, 4H), 4.08-4.13 (m, 2H), 4.20-4.36 (d, 2H), 7.54-7.62 (m, 5H), 7.84 (s, 1H), 8.30-8.32 (s, 1H), 9.22 (s, 1H), 12.26 (bs, 1H). LCMS MS (M+H)+ Calcd.: 526, Observ.: 526.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08664213B2uspto-grants-2014_03